Is a complete ETR/BXT research report available?

No complete published report is available for etr/BXT (ETR/BXT) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ETR/BXT (ETR/BXT)

Deutsche Börse Xetra: ETR/BXT · EUR

€0.21

-0.01 (-4.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ETR/BXT analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	25.8M
Net income (ttm)	-5.8M
EPS (ttm)	-€0.05
Volume	0
Beta	1.45

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -5.8M
EPS (ttm): -€0.05
Market cap: 25.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

All ETR/BXT indicators

Market & fundamental data

Available fields

138

Groups with data

Currency

CAD

Showing 138 of 138 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	DE
Employees Change	19%
Employees Change Percent	1,900
Enterprise value	EUR 29.8M
Exchange	Deutsche Börse Xetra
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	26.07
Industry PE Fwd	18.21
Last refreshed	2026-07-29
Market cap	EUR 25.8M
Price	EUR 0.21
Price currency	EUR
Sector	Healthcare
Sector PE	41.08
Sector PE Fwd	15.42
Sic	2834
Symbol	etr/BXT
Website	https://www.bionxt.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-22.35%
FCF yield	-10.76%
P/B ratio	-5.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -5.8M
ROA	-637.1
Roa5y	-280.5
ROCE	110

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-39.96%
Cagr3y	-13.5%
Cagr5y	-28.78%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 207,374
Cash	EUR 7,503
Current Assets	EUR 46,505
Current Liabilities	EUR 4.1M
Debt	EUR 3.9M
Debt FCF	EUR -1.41
Equity	EUR -4.5M
Interest Coverage	-4.42
Liabilities	EUR 4.8M
Long Term Assets	EUR 160,869
Long Term Liabilities	EUR 652,297
Net Cash	EUR -3.9M
Net Cash By Market Cap	EUR -15.12
Tangible Book Value	EUR -4.5M
Tangible Book Value Per Share	EUR -0.04
WACC	13.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.01
Net Working Capital	EUR -798,104
Quick ratio	0.01
Working Capital	EUR -4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-39.94%
200-day SMA	0.35
3Y total return	-35.29%
50-day SMA	0.23
50-day SMA vs 200-day SMA	50under200
5Y total return	-81.67%
All Time High	2.2
All Time High Change	-90.5%
All Time High Date	2020-05-29
All Time Low	0.1
All Time Low Change	109%
All Time Low Date	2023-10-23
ATR	0.03
Beta	1.45
Ch YTD	-53.03
High	0.22
High52	0.79
High52 Date	2025-08-07
High52ch	-73.54%
Low	0.21
Low52	0.19
Low52 Date	2026-07-06
Low52ch	10%
Ma50ch	-8.49%
Price vs 200-day SMA	-40.84%
RSI	48.14
RSI Monthly	39.33
RSI Weekly	35.25
Sharpe ratio	-0.3x
Sortino ratio	-0.41
Total Return	-6.73%
Tr YTD	-53.03
Tr1m	-14.69%
Tr1w	8.85%
Tr3m	-28.42%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -4.3M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	128,798,452%
Net Borrowing	778,457.9
Shares Insiders	5.33%
Shares Qo Q	2.78%
Shares Yo Y	6.73%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -4.6M
Adjusted OCF	-4,594,554.8
Average Volume	22,759.75x
Bv Per Share	-0.04
Ch1m	-14.69
Ch1w	8.85
Ch1y	-39.94
Ch3m	-28.42
Ch3y	-35.29
Ch5y	-81.67
Ch6m	-47.75
Change	-4.57%
Change From Open	-6.7
Close	0.22
Days Gap	2.28
Depreciation Amortization	-6,830.8
Earnings Date	2026-08-27
EBIT	EUR -4.3M
EBITDA	EUR -4.3M
EPS	EUR -0.05
F Score	2
FCF	EUR -2.8M
FCF EV Yield	-9.35x
Financing CF	2,532,612
Fiscal Year End	December
Founded	2,017
Income Tax	EUR -122,695
Investing CF	46,397
Is Primary Listing	0
Last Earnings Date	2025-11-28
Last Report Date	2026-03-31
Ma150	0.31
Ma150ch	-33.44%
Ma20	0.21
Ma20ch	0.19%
Net CF	-197,003
Next Earnings Date	2026-08-27
Open	0.22
Position In Range	0
Ppne	130,150.8
Price Date	2026-07-28
Relative Volume	0.43x
Share Based Comp	1,808,977
Tr6m	-47.75%
Volume	0

ETR/BXT (ETR/BXT)

Coverage state: Market snapshot only — no published research

Generate the first ETR/BXT analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/BXT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/BXT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ETR/BXT

Frequently asked questions